generics

Merger of Drugmakers Valeant, Actavis on Hold

AstraZeneca Q1 Sales Tumble as Generic Losses Bite Deep

South Africa Seeks to Close Drug Patent Loophole

UK Watchdog Accuses GSK Over 'Pay-for-delay' Drug Deals

Abbott Devices, Generics Struggle

Actavis to Sell Generic Yaz Birth Control After Ruling

Novartis Loses Landmark India Cancer Drug Patent Case

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

AstraZeneca Settles Crestor Patent Dispute

Roche Stays a Step Ahead of Copycat Drugmakers

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

Par to Pay $45 Million, End US Probes Over AIDS Appetite Drug

Generics Brought Down Common Drug Prices in 2012

India Rules Against Bayer in Cancer Drug Patent Case

Hikma Eyes Options for Injectables Business

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Amgen Biosimilar Push Takes Aim at Blockbusters

EU Regulators Charge J&J, Novartis Over Dutch Painkiller Delay

Endo Health in Talks with Potential Buyers

Eli Lilly Q4 Profits Hurt by Generic Competition

Actavis, Formerly Watson, Sees 2013 Profit Growth

Abbott Results Bode Well for Spun-off AbbVie

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

US FDA New Drug Approvals Hit 16-Year High in 2012

Number of New Drugs Picks Up in Europe and U.S.

With Teva at Crossroads, New CEO Set to Unveil Vision

Top EU Court Upholds AstraZeneca Fine Over Ulcer Drug

Teva's 2013 Forecast Is Below Wall Street Estimates

Bayer Sues Lupin Over Generic Birth Control Pill

Ranbaxy Halts Generic Lipitor Production After Recall

India's Ranbaxy Recalls Generic Lipitor in U.S.

Cipla to Bid $215 Million for Control of South Africa Affiliate

Topics • Technology

Orphan Drugs

Novartis CEO Says U.S. Plant Gets FDA Clearance

92 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Deutsche Post DHL

Thomson Reuters

CMS Advisors GmbH & Co. KG

Porsche Consulting

Camelot Management Consultants AG

Fitch Ratings

ARC Advisory Group GmbH & Co KG

Arthur D. Little

SchüllerConsulting

Camelot Management Consultants AG

Saltigo GmbH

Enigma Marketing Research

F. Hoffmann-La Roche Ltd